fibroid volume increased (24.3%) over the study period; however, patients randomized to green tea extract treatment showed significant reduction (32.6%) in total UF volume
As a long-term cancer survivor I research and write about cancer, its causes, its symptoms and most of all, how to cure it.
A frequently asked about cause of cancer on PeopleBeatingCancer is uterine fibroids (UF) aka endometrial polyps (EP). I posted a study that determined the average risk that UF/EP is cancerous is 2.5%.
While the possibility of a malignant (cancerous) polyps are on everyone’s mind, judging by the comments written after my post, there are a great many challenges that women who are diagnosed with UF/EP face including anemia, bleeding and the reduced chances of pregnancy. If you are a woman who has been diagnosed with UF/EP please consider the study’s findings below:
I take Green Tea extract to reduce the risk of many cancers including my own, multiple myeloma. The brand I take, Life Extension Foundation Mega Green Tea Extract contains the greatest amount of EGCG per capsule (326.25mg) supplement of the brands tested by ConsumerLab.com. (you must be a member to view this study). Good Luck.
For any other questions or comments about nutritional supplementation to manage cancer, scroll down the page, post a question or comment and I will reply ASAP.
“BACKGROUND: Uterine fibroids (UFs, also known as leiomyoma) affect 70% of reproductive-age women. Imposing a major burden on health-related quality-of-life (HRQL) of premenopausal women, UF is a public health concern. There are no effective medicinal treatment options currently available for women with symptomatic UF…
OBJECTIVES: To evaluate the efficacy and safety of green tea extract (epigallocatechin gallate [EGCG]) on UF burden and quality of life in women with symptomatic UF, in a double-blinded, placebo-controlled randomized clinical trial…
RESULTS: Of the final 39 women recruited for the study, 33 were compliant and completed all five visits of the study. In the placebo group (n = 11), fibroid volume increased (24.3%) over the study period; however, patients randomized to green tea extract (n = 22, 800 mg/day) treatment showed significant reduction (32.6%, P = 0.0001) in total UF volume. In addition, EGCG treatment significantly reduced fibroid-specific symptom severity (32.4%, P = 0.0001) and induced significant improvement in HRQL (18.53%, P = 0.01) compared to the placebo group. Anemia also significantly improved by 0.7 g/dL (P = 0.02) in the EGCG treatment group, while average blood loss significantly decreased from 71 mL/month to 45 mL/month (P = 0.001). No adverse effects, endometrial hyperplasia, or other endometrial pathology were observed in either group.
CONCLUSION: EGCG shows promise as a safe and effective therapeutic agent for women with symptomatic UFs. Such a simple, inexpensive, and orally administered therapy can improve women’s health globally.”